News

Click here to sign up to the OPDC News Mailing list

OPDC Participant's Open Day 2018

OPDC Participant's Open Day 2018

Posted 20/07/2018

On Monday 10th September, please join us for a FREE open afternoon of talks by our OPDC scientists and clinicians. Find out how your participation in the Discovery Cohort is improving our understanding of Parkinson's and driving us closer to a cure.

Profiles of Women in Science: Prof. Stephanie Cragg

Profiles of Women in Science: Prof. Stephanie Cragg

Posted 20/07/2018

Professor Stephanie Cragg is the co-lead of theme 3 in OPDC and was recently invited to give the The European Journal of Neuroscience special lecture at the 2018 FENS Forum in Berlin, Germany, where she spoke on Trees and gates: Dopamine axon arbours as filters of dopamine output. Professor Cragg was also interviewed for a profile in the journal. Follow this link for the full article.   A video interview with Professor Cragg can also be ...

Major new study launched to investigate the link between sleep problems and Parkinson’s

Major new study launched to investigate the link between sleep problems and Parkinson’s

Posted 13/07/2018

Researchers in the Oxford Parkinson’s Disease Centre are embarking on a new five-year study looking at the links between a condition known as Rapid Eye Movement Sleep Behaviour Disorder (RBD) and Parkinson’s. Funded by the NIHR Oxford Biomedical Research Centre, the study seeks to improve the remote diagnosis and monitoring of sleep problems at home.

Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases

Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases

Posted 10/05/2018

FORMA Therapeutics, the OPDC, and the Alzheimer’s Research UK Oxford Drug Discovery Institute (ODDI) at Oxford University announced today they have entered into a collaboration and license agreement to identify, validate and develop deubiquitinating enzyme (DUB) inhibitors for the treatment of neurodegenerative diseases. DUBs are a family of over a hundred proteases that play important roles in protein and cellular homeostasis, processes that ...

Congratulations from all at OPDC to Sally Bromley, chair of Parkinson's UK Oxford, on her honorary degree

Congratulations from all at OPDC to Sally Bromley, chair of Parkinson's UK Oxford, on her honorary degree

Posted 13/07/2018

Sally Bromley, chair of Parkinson's UK Oxford and much valued supporter of OPDC, has been bestowed with an honorary degree.

The Open University has officially awarded Sally Bromley the certificate, in recognition of her role supporting medical studies and helping other people with Parkinson's.

Mrs Bromley co-wrote the First Steps programme to help others through diagnosis, a workshop which helps people to come to terms with the condition.

 

Jonathan's Big Beautiful Wall Walk

Jonathan's Big Beautiful Wall Walk

Posted 09/05/2018

Jonathan Bromley, member of the Oxford branch of Parkinson's UK will be walking the length of Hadrians Wall over 5 days in June to raise money for Parkinson's UK. Jonathan's wife Sally (Chair of Oxford Parkinson's UK) was diagnosed with Parkinson's in 2008. Since then she has thrown herself wholeheartedly into fundraising and Parkinson's support work, and Jonathan thought it was about time he made a contribution too. I'm not roughing it ...

Students ‘meet the scientists’ at Dunn School

Students ‘meet the scientists’ at Dunn School

Posted 02/05/2018

As part of Science Experience Week organised by Science Oxford, students from three Oxfordshire secondary schools visited research-based organisations and faculties across the region to explore what a science-based career involves. One of their ‘experiences’ was to visit the University of Oxford’s Sir William Dunn School of Pathology to meet the resident scientists and learn about stem cell research. The students, from Matthew Arnold School, ...

OPDC's Professor Peter Magill and Dr Paul Dodson chosen as a focus of new Parkinson's UK fundraising appeal.

OPDC's Professor Peter Magill and Dr Paul Dodson chosen as a focus of new Parkinson's UK fundraising appeal.

Posted 24/04/2018

A new Parkinson's research project, led by OPDC scientists Professor Peter Magill and Dr Paul Dodson, was recently chosen by the charity Parkinson’s UK as a focus of its new fundraising appeal. As part of supporting the appeal, Peter hosted staff and lay members of Parkinson’s UK for a visit to the MRC Brain Network Dynamics Unit. Peter gave a tour of Unit labs and equipment, and was also interviewed about the science underpinning the new ...

Researchers develop a stem cell-based model of mitochondrial disease

Researchers develop a stem cell-based model of mitochondrial disease

Posted 09/04/2018

Mitochondria are the energy-producing factories inside cells. Sometimes genetic mutations can cause these factories to go wrong, leading to a number of neurological diseases. The same genetic mutation affecting mitochondrial function can result in a specific deficit such as loss of vision or a more complicated disorder such as Parkinson’s-like disease.  It is not yet known why the same mutation can have such varying effects. One gene that ...

Brain Awareness Week 2018

Brain Awareness Week 2018

Posted 23/03/2018

March 12-16th 2018 marked Brain Awareness Week with neuroscientists meeting the public to talk about research. OPDC's Imaging lead Professor Clare Mackay and Masud Husain, Professor of Neurology and Cognitive Neuroscience, spoke at a talk open to all about "New developments in Parkinson’s and Alzheimer’s research". In this accessible and informative public talk they explored the latest research into the debilitating neurodegenerative ...